Skip to content

A clinical cohort study of"olfactory three-needle" and "drum six-needle" to improve cognitive function in patients with AD spectrum

A clinical cohort study of"olfactory three-needle" and "drum six-needle" to improve cognitive function in patients with AD spectrum

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2024000346
Enrollment
Unknown
Registered
2024-09-01
Start date
2024-09-15
Completion date
Unknown
Last updated
2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

AD/MCI/SCD

Interventions

Olfactory Three-Needle:Bilateral Yingxiang Acupoint (LI20), Yintang Acupoint (GV29)
Drum Six-Needle:Bilateral Yingxiang Acupoint (LI20), Yintang Acupoint (GV29), Bilateral Neiguan Acupoint (PC6), Shenting Acupoint (GV23)

Sponsors

Nanjing Drum Tower Hospital Clinical College of Nanjing Medical University,China
Lead Sponsor

Eligibility

Sex/Gender
All
Age
55 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1) Age: 55-79 years old; 2) Write, eat, etc. with the right hand; 3) Physical health is basically good; 4) Educational level: junior high school and above; 5) No obvious visual impairment, no color blindness; no speech impediment; no serious hearing impediment; no limb movement impediment; 6) No contraindications to magnetic resonance, such as metal implants in the body (metal dentures), cardiac pacemakers, etc.; 7) No serious sinusitis, nonasal and sinus polyps, no history of nasal surgery, no occupying lesions such as tumors at the base of the skull or nasopharynx; 8) No other related diseases that seriously affect cognition, such as cerebral infarction, stroke, tumors, tuberculosis, etc.; 9) No other neuropsychiatric disorders, such as epilepsy, Parkinson's disease, depression, anxiety, etc.; 10) No chronic insomnia taking sleeping pills; no recent history of multiple general anesthesia surgeries.

Exclusion criteria

Exclusion criteria: 1. Inability to complete cognitive assessment or MRI scan, language dysfunction, severe visual/hearing impairment, contraindications to MRI scan; 2. Inability to cooperate with the "Smell and Brain" acupuncture intervention; 3. Cognitive impairment due to other known etiologies (e.g., stroke, craniocerebral injuries, alcohol dependence, epilepsy, depression, Parkinson's disease, or other neurological or psychiatric diseases); 4.Cognitive impairment due to other known causes (e.g. stroke, craniocerebral injury, alcohol dependence, epilepsy, depression, Parkinson's disease, or other neurological or psychiatric disorders); 4. Nasal lesions affecting olfactory function, including acute/chronic sinusitis, allergic rhinitis, and nasal polyps, etc.; 5. Failure to complete the follow-up examinations

Design outcomes

Primary

MeasureTime frame
Odor recognition;rs-fMRI;sMRI;AB(TMTA-B);MMSE;AVLT-H;AFT;SCD-Q;

Secondary

MeasureTime frame
TCM physique scale;FAQ;acceptability of survery;Z-score;GDS;

Countries

China

Contacts

Public Contactshijing

Nanjing Hospital of Chinese Medicine Affilicated to Nanjing University of Chinese Medicine, China

tlshij@163.com15077837569

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026